BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Saux N, Robinson JL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management. Paediatr Child Health 2015;20:441-50. [PMID: 26744558 DOI: 10.1093/pch/20.8.441] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Harel-Sterling M, Diallo M, Santhirakumaran S, Maxim T, Tessaro M. Emergency Department Resource Use in Pediatric Pneumonia: Point-of-Care Lung Ultrasonography versus Chest Radiography. J Ultrasound Med 2019;38:407-14. [PMID: 30027608 DOI: 10.1002/jum.14703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
2 Mathur S, Fuchs A, Bielicki J, Van Den Anker J, Sharland M. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018;38:S66-S75. [PMID: 29790844 DOI: 10.1080/20469047.2017.1409455] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
3 Scotta MC, Marostica PJ, Stein RT. Pneumonia in Children. Kendig's Disorders of the Respiratory Tract in Children. Elsevier; 2019. pp. 427-438.e4. [DOI: 10.1016/b978-0-323-44887-1.00025-0] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pernica JM, Harman S, Kam AJ, Carciumaru R, Vanniyasingam T, Crawford T, Dalgleish D, Khan S, Slinger RS, Fulford M, Main C, Smieja M, Thabane L, Loeb M. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial. JAMA Pediatr 2021;175:475-82. [PMID: 33683325 DOI: 10.1001/jamapediatrics.2020.6735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Blackburn J, Barrowman N, Bowes J, Tsampalieros A, Le Saux N; Canadian Pediatric Antimicrobial Stewardship Group. Establishing Benchmarks for Antimicrobial Use in Canadian Children's Hospitals: Results From 2 National Point Prevalence Surveys. Pediatr Infect Dis J 2021;40:899-905. [PMID: 34525004 DOI: 10.1097/INF.0000000000003170] [Reference Citation Analysis]
6 Alzomor O, Alhajjar S, Aljobair F, Alenizi A, Alodyani A, Alzahrani M, Aljubab A, Al Banyan E, Alshehri M, Alfwaz T, Alghoshimi M, Alhammadi M, Almazer Y, Elsidig N, Alghamdi F, Alsubaie S, Alshahrani D. Management of community-acquired pneumonia in infants and children: Clinical practice guidelines endorsed by the Saudi Pediatric Infectious Diseases Society. Int J Pediatr Adolesc Med 2017;4:153-8. [PMID: 30805522 DOI: 10.1016/j.ijpam.2017.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Pernica JM, Inch K, Alfaraidi H, Van Meer A, Carciumaru R, Luinstra K, Smieja M. Assessment of nasopharyngeal Streptococcus pneumoniae colonization does not permit discrimination between Canadian children with viral and bacterial respiratory infection: a matched-cohort cross-sectional study. BMC Infect Dis 2021;21:509. [PMID: 34059003 DOI: 10.1186/s12879-021-06235-z] [Reference Citation Analysis]
8 Alfaraidi H, Luinstra K, Eshaghi A, Smieja M, Gubbay JB, Pernica JM. Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study. BMJ Paediatr Open 2020;4:e000640. [PMID: 32411832 DOI: 10.1136/bmjpo-2020-000640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Matera MG, Rogliani P, Ora J, Cazzola M. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opin Pharmacother 2018;19:2043-53. [PMID: 30359143 DOI: 10.1080/14656566.2018.1534957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Nascimento-carvalho AC, Nascimento-carvalho CM. Clinical management of community-acquired pneumonia in young children. Expert Opinion on Pharmacotherapy 2019;20:435-42. [DOI: 10.1080/14656566.2018.1552257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
11 Le Saux NMA, Bowes J, Viel-Thériault I, Thampi N, Blackburn J, Buba M, Harrison MA, Barrowman N. Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016. Paediatr Child Health 2021;26:234-41. [PMID: 34136053 DOI: 10.1093/pch/pxaa066] [Reference Citation Analysis]
12 Singer A, Fanella S, Kosowan L, Falk J, Dufault B, Hamilton K, Walus A. Informing antimicrobial stewardship: factors associated with inappropriate antimicrobial prescribing in primary care. Fam Pract 2018;35:455-60. [PMID: 29237045 DOI: 10.1093/fampra/cmx118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A, Rodriguez-Ruiz JP, Malhotra-Kumar S, Powell C, Faust SN, Alcock AE, Hall D, Robinson G, Hawcutt DB, Lyttle MD, Gibb DM, Sharland M; PERUKI, GAPRUKI, and the CAP-IT Trial Group. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. JAMA 2021;326:1713-24. [PMID: 34726708 DOI: 10.1001/jama.2021.17843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dawson-Hahn EE, Mickan S, Onakpoya I, Roberts N, Kronman M, Butler CC, Thompson MJ. Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews. Fam Pract 2017;34:511-9. [PMID: 28486675 DOI: 10.1093/fampra/cmx037] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
15 Noël KC, Fontela PS, Winters N, Quach C, Gore G, Robinson J, Dendukuri N, Papenburg J. The Clinical Utility of Respiratory Viral Testing in Hospitalized Children: A Meta-analysis. Hosp Pediatr 2019;9:483-94. [PMID: 31167816 DOI: 10.1542/hpeds.2018-0233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mack I, Sharland M, Brussee JM, Rehm S, Rentsch K, Bielicki J. Insufficient Stability of Clavulanic Acid in Widely Used Child-Appropriate Formulations. Antibiotics (Basel) 2021;10:225. [PMID: 33672363 DOI: 10.3390/antibiotics10020225] [Reference Citation Analysis]
17 Markel M, Derraugh G, Lacher M, Iqbal S, Balshaw R, Min SAL, Keijzer R. Congenital lung malformation patients experience respiratory infections after resection: A population-based cohort study. Journal of Pediatric Surgery 2022. [DOI: 10.1016/j.jpedsurg.2021.12.042] [Reference Citation Analysis]
18 Le Saux N. Antimicrobial stewardship in daily practice: Managing an important resource. Paediatr Child Health 2014;19:261-70. [PMID: 24855430 DOI: 10.1093/pch/19.5.261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Tsegaw H, Yimam M, Nureye D, Woldeselassie W, Hambisa S. Predictors of Treatment Outcomes among Pediatric Patients Hospitalized with Pneumonia in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Adv Pharmacol Pharm Sci 2021;2021:6690622. [PMID: 33987540 DOI: 10.1155/2021/6690622] [Reference Citation Analysis]
20 Rajapakse NS, Vayalumkal JV, Vanderkooi OG, Ricketson LJ, Kellner JD. Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children. Paediatr Child Health 2016;21:65-6. [PMID: 27095876 DOI: 10.1093/pch/21.2.65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]